Dimension Capital has secured an $800 million investment vehicle, reinforcing the growing demand for the Science Compute Fund strategy across advanced technology sectors. The latest fund reflects rising investor confidence as scientific innovation increasingly combines with artificial intelligence and modern computing capabilities.
The New York-based venture capital firm announced its third fund only eighteen months after closing a previous $500 million vehicle. As a result, the newest fund represents approximately sixty percent growth, highlighting strong momentum despite slower fundraising across many venture capital firms.
Dimension Capital launched in late 2022 after partners Zavian Dar, Adam Goulburn, and Nan Li joined forces. Before creating the firm, the founders built investment experience across respected venture capital organizations while focusing on emerging technologies.
From the beginning, the partners believed entrepreneurs would increasingly develop companies combining biotechnology, software, and advanced computing solutions. Since then, market activity has strengthened that investment thesis much faster than the founders originally anticipated.
The firm’s strategy centers on identifying startups where scientific breakthroughs benefit directly from rapid advances in artificial intelligence and computing infrastructure. Consequently, the portfolio continues expanding into sectors that require both scientific expertise and sophisticated software development.
One of the firm’s notable investments arrived during 2024 through a co-led $30 million seed financing round for Chai Discovery. The company develops open-source artificial intelligence foundation models designed to improve drug discovery and pharmaceutical research processes.
Recently, Chai Discovery completed another funding round that raised $400 million while reaching a valuation of approximately $3.8 billion. That milestone demonstrated growing investor confidence in companies using artificial intelligence to accelerate scientific research and medical development.
Dimension Capital also invested in New Limit during the company’s Series A financing round completed in January 2025. The biotechnology startup focuses on anti-aging research while exploring new scientific approaches to cellular rejuvenation and human health improvements.
Earlier this month, New Limit secured additional financing through its Series C round, achieving a valuation near $3.1 billion. That achievement further strengthened Dimension Capital’s portfolio of science-focused companies attracting substantial institutional investment.
Beyond biotechnology, the venture capital firm maintains investments across artificial intelligence infrastructure and computing technologies supporting next-generation software applications. Therefore, its portfolio reflects growing demand for businesses operating where science and digital innovation increasingly overlap.
Among those investments, Modal Labs has emerged as another important portfolio company supporting advanced artificial intelligence inference capabilities. The firm also holds an investment position in Anthropic following a significant acquisition involving another portfolio company.
Earlier this year, Anthropic acquired drug discovery platform Coefficient Bio in a transaction reportedly valued at approximately $400 million. Through that acquisition, Dimension Capital received shares in Anthropic, expanding its exposure to one of the leading artificial intelligence companies.
The firm’s expanding portfolio illustrates how investors increasingly support startups blending scientific research with advanced computing capabilities. Moreover, successful funding rounds continue attracting additional capital toward businesses solving complex challenges through innovative technology.
The successful launch of the latest Science Compute Fund demonstrates continued confidence in companies building at the intersection of science and computing. As investment activity accelerates across artificial intelligence and biotechnology, Dimension Capital appears well positioned to pursue future opportunities within rapidly evolving technology markets.
